EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A conserved epitope in VAR2CSA is targeted by a cross-reactive antibody originating from Plasmodium vivax Duffy binding protein

Uwa Iyamu, Daniel Ferrer Vinals, Bernard Tornyigah, Eliana Arango, Rakesh Bhat, Trixie Rae Adra, Simranjit Grewal, Kimberly Martin, Amanda Maestre, Michael Overduin, Bart Hazes, Stephanie K Yanow

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1202276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Uwa Iyamu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, University of Alberta, Edmonton, AB, Canada. Hauptthemen laut MEDLINE: Malaria, Falciparum, Malaria, Vivax. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Li Ka Shing Institute of Virology, University of Alberta.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During Plasmodium falciparum infection in pregnancy, VAR2CSA is expressed on the surface of infected erythrocytes (IEs) and mediates their sequestration in the placenta. As a result, antibodies to VAR2CSA are largely restricted to women who were infected during pregnancy. However, we discovered that VAR2CSA antibodies can also be elicited by P. vivax Duffy binding protein (PvDBP). We proposed that infection with P. vivax in non-pregnant individuals can generate antibodies that cross-react with VAR2CSA. To better understand the specificity of these antibodies, we took advantage of a mouse monoclonal antibody (3D10) raised against PvDBP that cross-reacts with VAR2CSA and identified the epitopes targeted by this antibody. We screened two peptide arrays that span the ectodomain of VAR2CSA from the FCR3 and NF54 alleles. Based on the top epitope recognized by 3D10, we designed a 34-amino acid synthetic peptide, which we call CRP1, that maps to a highly conserved region in DBL3X. Specific lysine residues are critical for 3D10 recognition, and these same amino acids are within a previously defined chondroitin sulfate A (CSA) binding site in DBL3X. We showed by isothermal titration calorimetry that the CRP1 peptide can bind directly to CSA, and antibodies to CRP1 raised in rats significantly blocked the binding of IEs to CSA in vitro . In our Colombian cohorts of pregnant and non-pregnant individuals, at least 45% were seroreactive to CRP1. Antibody reactivities to CRP1 and the 3D10 natural epitope in PvDBP region II, subdomain 1 (SD1), were strongly correlated in both cohorts. These findings suggest that antibodies arising from PvDBP may cross-react with VAR2CSA through the epitope in CRP1 and that CRP1 could be a potential vaccine candidate to target a distinct CSA binding site in VAR2CSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria, FalciparumMalaria, VivaxPregnancyMiceFemaleRatsAnimalsPlasmodium vivaxEpitopesPlasmodium falciparumAntibodies, ProtozoanAntigens, ProtozoanPlacentaChondroitin SulfatesErythrocytesProtein Binding

Stichwörter der Autor:innen

PvDBPVAR2CSAcross-reactivitymalariapeptidepregnancyvaccine design

Substanzen

EpitopesAntibodies, ProtozoanAntigens, ProtozoanChondroitin Sulfates

Autor:innen und Institutionen

  • School of Public Health, University of Alberta, Edmonton, AB, Canada.
  • Grupo Salud y Comunidad, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
  • Grupo de Enfermedades Infecciosas y Crónicas (GEINCRO), Fundación Universitaria San Martín, Sabaneta, Colombia.
  • Department of Biochemistry, University of Alberta, Edmonton, AB, Canada.
  • Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada.

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Li Ka Shing Institute of Virology, University of Alberta
  • Canadian Institutes of Health Research
  • Canada Foundation for Innovation
  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Iyamu, U., Vinals, D. F., Tornyigah, B., Arango, E., Bhat, R., Adra, T. R., Grewal, S., Martin, K., Maestre, A., Overduin, M., Hazes, B., & Yanow, S. K. (2023). A conserved epitope in VAR2CSA is targeted by a cross-reactive antibody originating from Plasmodium vivax Duffy binding protein. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1202276

Vancouver

Iyamu U, Vinals DF, Tornyigah B, Arango E, Bhat R, Adra TR, et al. A conserved epitope in VAR2CSA is targeted by a cross-reactive antibody originating from Plasmodium vivax Duffy binding protein. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1202276

BibTeX
@article{Iyamu2023,
  author = {Iyamu, Uwa and Vinals, Daniel Ferrer and Tornyigah, Bernard and Arango, Eliana and Bhat, Rakesh and Adra, Trixie Rae and Grewal, Simranjit and Martin, Kimberly and Maestre, Amanda and Overduin, Michael and Hazes, Bart and Yanow, Stephanie K},
  title = {A conserved epitope in VAR2CSA is targeted by a cross-reactive antibody originating from Plasmodium vivax Duffy binding protein},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1202276}
}
Kostenlos starten →